Skip to content

Isoxsuprine in prevention of preterm labor

Effect of maintenance therapy with Isoxsuprine in prevention of preterm labor

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101115591N1
Enrollment
81
Registered
2011-06-08
Start date
2009-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labour

Interventions

Intervention 1: In case group: Isoxsuprine 10 mg tablet TDS since 26 wk continue throughout pregnancy. Intervention 2: In control group: Placebo tablet TDS since 26 wk continue throughout pregnancy.
Treatment - Drugs
Placebo
In case group: Isoxsuprine 10 mg tablet TDS since 26 wk continue throughout pregnancy.
In control group: Placebo tablet TDS since 26 wk continue throughout pregnancy.

Sponsors

Vice-chancellor for research of Hormozgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-pregnant women, 2-singleton pregnancy, 3-gestational age 26-34 weeks, 4-preterm labor pain, 5-intact amniotic membrane. Exclusion criteria: 1-gestational age >34 wk, 2-premature rupture of membrane, 3-chorioamnionitis, 4-antepartum hemorrhage (abraption, placental, previa), 5-multiple pregnancy, 6-systemic diseases (preclampsia, diabetes melitus, cardiovascular disorders, renal diseases, asthma, hyperthyroidy,...), 7-congenital abnormality, 8-urinary tract infection, 9-past history of preterm labor.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Contractions stop for 48 hours. Timepoint: From stop of premature contractions. Method of measurement: hour.;Stop of contraction for one week. Timepoint: Since stop of contraction. Method of measurement: week.;Stop of contraction till 34 wks of gestation. Timepoint: Since stop of contraction. Method of measurement: week.;Term delivery. Timepoint: 37 wk of gestation till delivery. Method of measurement: week.

Secondary

MeasureTime frame
Side effects. Timepoint: during pregnancy. Method of measurement: pulse rate, respiratory rate, blood pressure.;NICU admission. Timepoint: from time of birth. Method of measurement: day.;Apgar 1st and 5th minutes. Timepoint: from time of birth. Method of measurement: Score 10/10.;Birth weight. Timepoint: time of birth. Method of measurement: kg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlavi Azin

Hormozgan University of Medical Sciences

alavi-a@razi.tums.ac.ir+98 76 1333 3625

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026